GlassScriptPhysician profile
Richard P Manes
NPI 1104077650
$66,939.56
in general payments reported to CMS, 2019-2025
14 companies · $54K in 2025
The $54K reported for 2025 was more than what 99% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $586 · 2020: $150 · 2021: $93.79 · 2022: $82.34 · 2023: $2,144 · 2024: $9,986 · 2025: $54K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $49K · Travel and Lodging: $14K · Food and Beverage: $3,703.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $48,505.00 |
| Travel and Lodging | $13,818.87 |
| Food and Beverage | $3,703.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurent Medical Limited | $60,130.79 | 2023-2025 | Neuromark Radiofrequency Console, Neuromark System, Neuromark Device |
| Spirair, INC. | $1,607.40 | 2025 | Turbalign, Septalign |
| Medtronic, INC. | $1,441.52 | 2023-2025 | Hydrodebrider, Sinuva, Stealthstation S8 Platform |
| Genzyme Corporation | $1,441.18 | 2023-2024 | |
| Integra Lifesciences Corporation | $958.06 | 2024-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Intersect Ent, INC. | $390.53 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $272.12 | 2021-2025 | Dupixent |
| Medtronic USA, INC. | $262.40 | 2019-2020 | |
| Aerin Medical INC. | $124.58 | 2022-2024 | |
| Stryker Corporation | $111.33 | 2025 | Xpress Loprofile, Scopis Ent |
| Glaxosmithkline, LLC. | $94.50 | 2022-2023 | Nucala |
| Optinose US, INC. | $83.15 | 2019 | |
| Acclarent, INC | $22.00 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Manes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.